* Alignment Healthcare Inc ALHC.OQ ALHC.O is expected
to show
a rise in quarterly revenue when it reports results on February
28.
* The Orange California-based company is expected to report
a
14.4% increase in revenue to $341.114 million from $298.27
million a year ago, according to the mean estimate from 8
analysts, based on Refinitiv data. The company's guidance on
November 3 2022, for the period ended December 31, was for
revenue between $338.00 million and $343.00 million.
* Refinitiv's mean analyst estimate for Alignment
Healthcare Inc
is for a loss of 30 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Alignment
Healthcare Inc is $19, above its last closing price of $9.27.
The company's guidance on November 3 2022 for the period ended
December 31 was for Earnings before Interest, Taxes,
Depreciation and Amortization of between 338 million and -27
million (USD).
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 -0.24 -0.25 -0.22 Beat 10.5
Jun. 30 2022 -0.26 -0.26 -0.06 Beat 76.7
Mar. 31 2022 -0.25 -0.25 -0.23 Beat 6.5
Dec. 31 2021 -0.31 -0.30 -0.27 Beat 9.6
Sep. -0.17 -0.17 -0.26 Missed -51.5
30 2021
Jun. 30 2021 -0.11 -0.11 -0.25 Missed -127.3
Mar. 31 2021 -0.19 -0.19 -0.35 Missed -84.2
This summary was machine generated February 25 at 03:08 GMT.
All figures in US dollars unless otherwise stated